FDA Clearance Tracker · K161158
IDS-iSYS Intact PTHN
Last checked: Nov 20, 2026Latest source record: Jan 31, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Jan 31, 2017
Substantially Equivalent
Time to decision
281 days
Received Apr 25, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K161158
- Device name
- IDS-iSYS Intact PTHN
- Applicant
- Immunodiagnostic Systems , Ltd.
- Applicant location
- Boldon, GB
- Received
- Apr 25, 2016
- Decided
- Jan 31, 2017
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Radioimmunoassay, Parathyroid Hormone (CEW)
- Device class
- Class II
- Regulation
- 21 CFR 862.1545
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code CEW. The earliest in FDA's data is K771783, decided Oct 14, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K161158
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Immunodiagnostic Systems , Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- IDS Cortisol510(k)
K202136 · Decided Apr 13, 2021 · 256 days after receipt
Device type: Radioimmunoassay, Cortisol (CGR) · Laboratory Medicine & Pathology
- IDS-iSYS Ostase BAP510(k)
K200475 · Decided Sep 30, 2020 · 217 days after receipt
Device type: Electrophoretic Separation, Alkaline Phosphatase Isoenzymes (CIN) · Laboratory Medicine & Pathology
- IDS SHBG510(k)
K190121 · Decided Jun 17, 2019 · 143 days after receipt
Device type: Radioimmunoassay, Testosterones And Dihydrotestosterone (CDZ) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.